256 related articles for article (PubMed ID: 24033321)
1. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.
Patel AR; Kowlessar BS; Donaldson GC; Mackay AJ; Singh R; George SN; Garcha DS; Wedzicha JA; Hurst JR
Am J Respir Crit Care Med; 2013 Nov; 188(9):1091-9. PubMed ID: 24033321
[TBL] [Abstract][Full Text] [Related]
2. Aortic Pulse Wave Velocity as a Measure of Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Two-Year Follow-Up Data from the ARCADE Study.
Gale NS; Albarrati AM; Munnery MM; Mcdonnell BJ; Benson VS; Singer RMT; Cockcroft JR; Shale DJ
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987061
[No Abstract] [Full Text] [Related]
3. Changes in biomarkers of cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease.
Shafuddin E; Chang CL; Cooray M; Tuffery CM; Hopping SJ; Sullivan GD; Jacobson GA; Hancox RJ
Respir Med; 2018 Dec; 145():192-199. PubMed ID: 30509708
[TBL] [Abstract][Full Text] [Related]
4. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
Fu JJ; McDonald VM; Baines KJ; Gibson PG
Chest; 2015 Sep; 148(3):618-629. PubMed ID: 25950204
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations.
Mackay AJ; Donaldson GC; Patel AR; Jones PW; Hurst JR; Wedzicha JA
Am J Respir Crit Care Med; 2012 Jun; 185(11):1218-24. PubMed ID: 22281834
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory changes, recovery and recurrence at COPD exacerbation.
Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
[TBL] [Abstract][Full Text] [Related]
7. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.
Baines KJ; Fu JJ; McDonald VM; Gibson PG
Int J Chron Obstruct Pulmon Dis; 2017; 12():541-550. PubMed ID: 28223794
[TBL] [Abstract][Full Text] [Related]
8. Association Between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease.
Andrijevic L; Milutinov S; Andrijevic I; Jokic D; Vukoja M
Balkan Med J; 2017 May; 34(3):226-231. PubMed ID: 28443567
[TBL] [Abstract][Full Text] [Related]
9. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD.
Chang CL; Robinson SC; Mills GD; Sullivan GD; Karalus NC; McLachlan JD; Hancox RJ
Thorax; 2011 Sep; 66(9):764-8. PubMed ID: 21474497
[TBL] [Abstract][Full Text] [Related]
10. Cardiac dysfunction in exacerbations of chronic obstructive pulmonary disease is often not detected by electrocardiogram and chest radiographs.
Shafuddin E; Chang CL; Cooray M; McAnulty KA; Karalus NC; Lee MHS; Hancox RJ
Intern Med J; 2019 Jun; 49(6):761-769. PubMed ID: 30324703
[TBL] [Abstract][Full Text] [Related]
11. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.
Wedzicha JA; Seemungal TA; MacCallum PK; Paul EA; Donaldson GC; Bhowmik A; Jeffries DJ; Meade TW
Thromb Haemost; 2000 Aug; 84(2):210-5. PubMed ID: 10959691
[TBL] [Abstract][Full Text] [Related]
12. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
[TBL] [Abstract][Full Text] [Related]
13. [Arterial stiffness in patients with chronic obstructive lung disease in the presence and absence of ischemic heart disease].
Karoli NA; Dolishniaia GR; Rebrov AP
Kardiologiia; 2013; 53(7):56-61. PubMed ID: 24087962
[TBL] [Abstract][Full Text] [Related]
14. NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
Labaki WW; Xia M; Murray S; Curtis JL; Barr RG; Bhatt SP; Bleecker ER; Hansel NN; Cooper CB; Dransfield MT; Wells JM; Hoffman EA; Kanner RE; Paine R; Ortega VE; Peters SP; Krishnan JA; Bowler RP; Couper DJ; Woodruff PG; Martinez FJ; Martinez CH; Han MK
Respir Med; 2018 Jul; 140():87-93. PubMed ID: 29957287
[TBL] [Abstract][Full Text] [Related]
15. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease.
Seemungal TA; Harper-Owen R; Bhowmik A; Jeffries DJ; Wedzicha JA
Eur Respir J; 2000 Oct; 16(4):677-83. PubMed ID: 11106212
[TBL] [Abstract][Full Text] [Related]
16. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
17. Disconnection of pulmonary and systemic arterial stiffness in COPD.
Weir-McCall JR; Liu-Shiu-Cheong PS; Struthers AD; Lipworth BJ; Houston JG
Int J Chron Obstruct Pulmon Dis; 2018; 13():1755-1765. PubMed ID: 29881265
[TBL] [Abstract][Full Text] [Related]
18. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
19. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
Wilkinson TMA; Hurst JR; Perera WR; Wilks M; Donaldson GC; Wedzicha JA
Chest; 2006 Feb; 129(2):317-324. PubMed ID: 16478847
[TBL] [Abstract][Full Text] [Related]
20. Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation.
Vanfleteren LE; Spruit MA; Groenen MT; Bruijnzeel PL; Taib Z; Rutten EP; Op 't Roodt J; Akkermans MA; Wouters EF; Franssen FM
Eur Respir J; 2014 May; 43(5):1306-15. PubMed ID: 24311762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
